Analysis of the Strong Performance of Maiwei Shares (300751)

The core catalyst for Maiwei Shares’ recent strong performance is the company’s signing of the industry’s first entire line supply contract for perovskite/silicon heterojunction tandem solar cells. This is the first commercial entire line order in the tandem solar cell field, marking that the company’s technical reserves and commercialization capabilities have been recognized by the market [1][2]. As a next-generation photovoltaic technology, tandem solar cells have higher conversion efficiency and lower costs, with extremely high market expectations. This order has driven the stock price to rise sharply [0][1].

The stock is in an uptrend, breaking through the resistance level of $205.32 to hit a record high on the day. The next target level is $218.39, and the support level is $166.54. The KDJ indicator shows a bullish trend, but the RSI overbought signal indicates short-term fluctuation risks [0]. The trading volume was nearly 20.02M, twice the average volume, showing high attention from market funds [0].

The company has solid fundamentals with an ROE of 10.79% and a net profit margin of 10.05%. The latest quarterly EPS exceeded expectations by 36.34% [0]. The current P/E ratio is 68.82x, higher than the industry average, but the high growth potential of tandem solar cell technology supports the valuation [0]. In terms of sectors, photovoltaic equipment and perovskite solar cell concepts led the gains, with many stocks hitting their daily limit. Institutions are optimistic about the prospects of tandem solar cells in space applications, and market sentiment is positive [2][3].

1. The breakthrough in tandem solar cell technology brings a long-term growth logic for the company. The first commercial order verifies its technology implementation capability and will drive valuation reconstruction [1][0].
2. The sector effect has strengthened the momentum of the stock price rise. The improvement in industry fundamentals and technological iteration have jointly supported market confidence [2][0].
3. Short-term overbought and high valuation require vigilance against correction risks, but the long-term growth space still depends on sustained technological leadership and the speed of order implementation [0].

• Valuation Correction Risk
  : The current P/E ratio is higher than the industry average, and excessive short-term gains may trigger profit-taking [0].
• Technological Iteration Risk
  : Photovoltaic technology updates rapidly; if the company fails to maintain technological leadership, its long-term competitiveness will be affected [0].
• Policy and Market Fluctuation Risk
  : The photovoltaic industry is greatly affected by policies, and fluctuations in market demand may affect order stability [0].

• Tandem solar cell technology is in the early stage of commercialization. As a pioneer, the company is expected to seize the market opportunity [1][2].
• The industry has broad prospects; institutions predict that tandem solar cells will play an important role in the space photovoltaic field after 2028 [3].

Maiwei Shares’ strong performance is driven by the commercial order for tandem solar cells, with technical, fundamental, and market environment factors jointly supporting the rise. In the short term, attention should be paid to overbought and valuation risks; in the long term, it depends on sustained technological breakthroughs and order implementation. Investors should make decisions based on their own risk preferences and long-term growth expectations.